谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Abstract PS11-11: Targeted safety events from a phase I/Ib study evaluating GDC-0077 alone and in combination with endocrine therapy (ET) ± palbociclib (palbo) in patients (pts) withPIK3CA-mutant (mut), hormone receptor-positive/HER2-negative metastatic breast cancer (HR+/HER2- mBC)

Mafalda Olivera,Komal Jhaveri,Dejan Juric,Philippe L Bedard,Andrés Cervantes,Valentina Gambardella,Erika Hamilton,Antoine Italiano,Kevin Kalinsky,Ian E Krop,Peter Schmid,Nicolas Turner,Andrea Varga,Guiyuan Lei,Stephanie Royer-Joo,Piia Thomas,Jennifer L Schutzman,Cristina Saura

Poster Session Abstracts（2021）

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要